Heliox inhalation therapy for bronchiolitis in infants

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Liet, Jean Michel ^a   Ducruet, Thierry ^b   Gupta, Vineet ^c   Cambonie, Gilles ^d  

^a Hopital Mere Enfant CHU de Nantes   (France)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MOSES H CONE MEMORIAL HOSPITAL   (United States)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOX; BRONCHODILATING AGENT; HELIUM; OXYGEN;

ACUTE DISEASE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; DISEASE SEVERITY; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; HELIOX INHALATION THERAPY; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HUMAN; INFANT; LENGTH OF STAY; LUNG COMPLIANCE; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; OXYGEN SATURATION; OXYGEN THERAPY; PEDIATRIC INTENSIVE CARE UNIT; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; BRONCHIOLITIS, VIRAL; COMPLICATION; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL VIRUS INFECTION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; HELIUM; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; INTUBATION, INTRATRACHEAL; LENGTH OF STAY; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84963807012     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006915.pub3     Document Type: Review

References (84)

1. Cambonie G, Milési C, Fournier-Favre S, Counil F, Jaber S, Picaud JC, et al. Clinical effects of heliox administration for acute bronchiolitis in young infants. Chest 2006;129(3):676-82.
2. Chowdhury MM, McKenzie SA, Pearson CC, Carr S, Pao C, Shah AR, et al. Heliox therapy in bronchiolitis: phase III. multicenter double-blind randomized controlled trial. Pediatrics 2013;131(4):661-9.
3. Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, PerloffW, Zimmerman J, et al. Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Critical Care Medicine 1998;26(10):1731-6.
4. Kim IK, Phrampus E, Sikes K, Pendleton J, Saville A, Corcoran T, et al. Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. Archives of Pediatrics and Adolescent Medicine 2011;165(12):1115-22.
5. Kneyber MC, van Heerde M, Twisk JW, Plötz FB, Markhors DG. Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure. Critical Care 2009;13(3):R71.
6. Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, et al. Noninvasive therapy with helium-oxygen for severe bronchiolitis. Journal of Pediatrics 2005;147(6):812-7.
7. Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox versus air oxygen in infants with acute bronchiolitis: a crossover study. Pediatrics 2008;121(5):e1190-6.
8. Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatric Critical Care Medicine 2003;4(3):353-7.
9. Colnaghi M, Pierro M, Migliori C, Ciralli F, Matassa PG, Vendettuoli V, et al. Nasal continuous positive airway pressure with heliox in preterm infants with respiratory distress syndrome. Pediatrics 2012;129(2):e333-8.
10. Dieperink W, Knol JA, Boersma HJ, Eindhoven GB, Aarts LP, Goorhuis JF, et al. Combination of heliox and CPAP without a ventilator: bench test and clinical observations. European Journal of Anaesthesiology 2007;24(10):889-91.
11. Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Canadian Anaesthetists' Society Journal 1979;26(3):206-12.
12. Elleau C, Galperine RI, Guenard H, Demarquez JL. Helium-oxygen mixture in respiratory distress syndrome: a double-blind study. Journal of Pediatrics 1993;122(1):132-6.
13. Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Critical Care 2000;4(3):188-92.
14. Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-4.
15. Gupta VK, Grayck EN, Cheifetz IM. Heliox administration during high-frequency jet ventilation augments carbon dioxide clearance. Respiratory Care 2004;49(9):1038-44.
16. Iglesias Fernández C, López-Herce Cid J, Mencía Bartolomé S, Santiago Lozano MJ, Moral Torrero R, Carrillo Alvarez A. Efficacy of heliox therapy in respiratory insufficiency in infants and children [Eficacia del tratamiento con heliox en ninos con insuficiencia respiratoria]. Anales de Pediatría 2007;66(3):240-7.
17. Isakov IuF, Mikhel'son VA, Anokhin MI, Ostrekov IF, Dianov AG. Inhalation of helium in the complex treatment of children with respiratory insufficiency. Khirurgiia 1970;46(4):145-9.
18. Kneyber MC, van Heerde M, Markhorst DG, Plötz FB. Mechanical ventilation with heliox decreases respiratory system resistance and facilitates CO2 removal in obstructive airway disease. Intensive Care Medicine 2006;32(10):1676-7.
19. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109:68-73.
20. Martinón-Torres F, Crespo Suárez PA, Silvia Barbàra C, Castelló Muñoz A, Rodríguez Núñez A, Martinón Sánchez JM. Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome [Ventilacion no invasiva con heliox en un lactante con sindrome de dificultad respiratoria aguda]. Anales de Pediatría 2005;62(1):64-7.
21. Martinón-Torres F, Rodríguez-Núñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respiratory Medicine 2006;100(8):1458-62.
22. Mayordomo-Colunga J, Medina A, Rey C, Concha A, Los Arcos M, Menéndez S. Helmet-delivered continuous positive airway pressure with heliox in respiratory syncytial virus bronchiolitis. Acta Paediatrica 2010;99(2):308-11.
23. Montaguti A, Frontalini S, Carleo A, Deha A, Franceschi A, Lampugnani E, et al. Noninvasive ventilation for acute respiratory failure. Pediatric Critical Care Medicine 2011;12(Suppl 3):A83.
24. Paret G, Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Heliox in respiratory failure secondary to bronchiolitis: a new therapy. Pediatric Pulmonology 1996;22(5):322-3.
25. Tobias JD. Heliox in children with airway obstruction. Pediatric Emergency Care 1997;13(1):29-32.
26. Tobias JD, Grueber RE. High-frequency jet ventilation using a helium-oxygen mixture. Paediatric Anaesthesia 1999;9(5):451-5.
27. Ulhôa CA, Larner L. Helium-oxigen (Heliox) mixture in airway obstruction. Jornal de Pediatria 2000;76(1):73-8.
28. Williams J, Stewart K, Tobias JD, Berkenbosch JW. Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula. Pediatric Emergency Care 2004;20(9):574-78.
29. Winters JW, Willing MA, Sanfilippo D. Heliox improves ventilation during high-frequency oscillatory ventilation in pediatric patients. Pediatric Critical Care Medicine 2000;1(1):33-7.
30. ClinicalTrials.gov identifier: NCT02373683. Ongoing study February 2015.
31. American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 2006;118(4):1774-93. [MEDLINE: 17015575]
32. Barach AL. The therapeutic use of helium. Journal of the American Medical Association 1936;107:1273-80.
33. Beggs S, Wong ZH, Kaul S, Ogden KJ, Walters JA. High-flow nasal cannula therapy for infants with bronchiolitis. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD009609.pub2]
34. Berkenbosch JW, Grueber RE, Dabbagh O, McKibben AW. Effect of helium-oxygen (heliox) gas mixtures on the function of four pediatric ventilators. Critical Care Medicine 2003;31(7):2052-8. [MEDLINE: 12847403]
35. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. Journal of Pediatrics 2000;137(6):865-70.
36. Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. European Journal of Pediatrics 2013;172(12):1649-56.
37. Byington CL, Wilkes J, Korgenski K, Sheng X. Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Journal of Pediatrics 2015;135(1):e24-31.
38. Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Doménech E, Figueras-Aloy J, et al. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group. Pediatric Infectious Disease Journal 2000;19(7):592-7.
39. Carter ER, Webb CR, Moffitt DR. Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial. Chest 1996;109(5):1256-61.
40. Chevret L, Mbieleu B, Essouri S, Durand P, Chevret S, Devictor D. Bronchiolitis treated with mechanical ventilation: prognosis factors and outcome in a series of 135 children. Archives de Pédiatrie 2005;12(4):385-90. [MEDLINE: 15808426]
41. Corcoran TE, Gamard S. Development of aerosol drug delivery with helium oxygen gas mixtures. Journal of Aerosol Medicine 2004;17(4):299-309.
42. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatric Critical Care Medicine 2004;5(5):482-9. [MEDLINE: 16684365]
43. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, et al. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatric Infectious Disease Journal 2008;27(9):788-93.
44. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
45. McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT: GRADEpro Guideline Development Tool. Available from www.gradepro.org. Hamilton: McMaster University (developed by Evidence Prime, Inc.), 2015.
46. Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatric Critical Care Medicine 2005;6:204-11. [MEDLINE: 15730610]
47. Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Current Topics in Microbiology and Immunology 2013;372:39-57.
48. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
49. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
50. Hough JL, Pham TM, Schilber A. Physiologic effects of high-flow nasal cannula in infants with bronchiolitis. Pediatric Critical Care Medicine 2014;15(5):e214-9.
51. Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Critical Care Medicine 1991;19(3):356-9.
52. Kudukis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. Journal of Pediatrics 1997;130(2):217-24.
53. Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatric Infectious Disease Journal 2004;23(9):806-14.
54. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
55. Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH, et al. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. European Journal of Pediatrics 2003;162(4):230-6.
56. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987;76(6):939-45.
57. Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Archives of Pediatrics and Adolescent Medicine 2012;166(8):769-70.
58. Martinon-Torres F. Noninvasive ventilation with helium-oxygen in children. Journal of Critical Care 2012;27(2):e1-9.
59. Martinón-Torres F. What's weighing down heliox?. Lancet Respiratory Medicine 2015;3(1):14-5.
60. Mayfield S, Bogossian F, O'Malley L, Schibler A. High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. Journal of Paediatrics and Children Health 2014;50(5):373-8.
61. McKiernan C, Chua LC, Visintainer PF, Allen H. High flow nasal cannulae therapy in infants with bronchiolitis. Journal of Pediatrics 2010;156:634-8.
62. Meert K, Heidemann S, Abella B, Sarnaik A. Does prematurity alter the course of respiratory syncytial virus infection?. Critical Care Medicine 1990;18(12):1357-9. [MEDLINE: 2245609]
63. Milési C, Baleine J, Matecki S, Durand S, Combes C, Novais AR, et al. Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Medicine 2013;39(6):1088-94.
64. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375(9725):1545-55.
65. Panitch HB. Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. Pediatric Infectious Disease Journal 2003;22(Suppl):83-7. [MEDLINE: 12671457]
66. Piedimonte G. Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respiratory Research 2002;3(Suppl 1):21-5.
67. Prais D, Schonfeld T, Amir J, Israeli Respiratory Syncytial Virus Monitoring Group. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 2004;113(3 Pt 1):629. [MEDLINE: 12949282]
68. Ralston S, Hill V. Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review. Journal of Pediatrics 2009;155(5):728-33.
69. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
70. Roche-Campo F, Vignaux L, Galia F, Lyazidi A, Vargas F, Texereau J, et al. Delivery of helium oxygen mixture during spontaneous breathing: evaluation of three high-concentration face masks. Intensive Care Medicine 2011;37:1787-92.
71. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for non-intubated acute asthma patients. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD002884.pub2]
72. Schibler A, Pham TM, Dunster KR, Foster K, Barlow A, Gibbons K, et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Medicine 2011;37:847-52.
73. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. Journal of Pediatrics 2003;143(5 Suppl):118-26.
74. Skjerven HO, Hunderi JO, Brügmann-Pieper SK, Brun AC, Engen H, Eskedal L, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. New England Journal of Medicine 2013;368(24):2286-93.
75. Standley TD, Smith HL, Brennan LJ, Wilkins IA, Bradley PG, Barrera Groba C, et al. Room air dilution of heliox given by facemask. Intensive Care Medicine 2008;34(8):1469-76.
76. Stillwell PC, Quick JD, Munro PR, Mallory GB Jr. Effectiveness of open-circuit and oxyhood delivery of helium-oxygen. Chest 1989;95(6):1222-4.
77. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. Journal of Pediatrics 1995;126(2):212-9. [MEDLINE: 7844667]
78. Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):E96.
79. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. Journal of Pediatrics 2003;143(Suppl):112-7. [MEDLINE: 14615709]
80. Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW Jr. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. Journal of Pediatrics 1984;104(5):752-7. [MEDLINE: 6546945]
81. Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus. American Journal of Diseases of Children 1972;123(3):227-8.
82. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD006458.pub2]
83. Liet JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006915]
84. Liet JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD006915.pub2]